Author: Dr. Grégoire Wuerzner

  • Management of Arterial Hypertension: From Therapeutic Inertia to Patient Empowerment
    By

    Dr. Grégoire Wuerzner

    ,

    Prof. Michel Burnier

    and

    al.

    Management of Arterial Hypertension: From Therapeutic Inertia to Patient Empowerment

    Prof. MICHEL BURNIER, Drs. ERIETTA POLYCHRONOPOULOU and GRÉGOIRE WUERZNER

    Continue Reading

  • New Blood Pressure Targets: Much Ado About Nothing?
    By

    Dr. Antoinette Pechère-Bertschi

    ,

    Dr. Grégoire Wuerzner

    and

    Prof. Michel Burnier

    New Blood Pressure Targets: Much Ado About Nothing?

    How can we accept the lowering of blood pressure targets in daily practice when more than half of treated hypertensive patients have blood pressure values above the "former" targets? The publication of new guidelines concerning the diagnosis of hypertension and the target blood pressure levels to be achieved routinely plunges us back into an almost Lelouch-like question: What was it all for?

    Continue Reading

  • Optimizing hypertension management in renal transplantation: a call to action
    By

    Dr. Antoinette Pechère-Bertschi

    ,

    Dr. Grégoire Wuerzner

    ,

    Prof. Michel Burnier

    and

    al.

    Optimizing hypertension management in renal transplantation: a call to action

    Cardiovascular events represent a major cause of death in renal transplant patients [1,2]. Renal transplant recipients also constitute a population at very high risk for progressive graft loss and renal events. Although immunological risk factors play an important role in renal survival, it is less recognized that hypertension is probably the major nonimmunological risk factor for graft loss [2]. Accurate diagnosis of hypertension and adequate control of blood pressure (BP) is considered as a fundamental goal in the management of renal transplant patients to lower their cardiovascular and renal risk. However, diagnosis, treatment and monitoring of hypertension remain suboptimal in most renal transplant patients [3]. This editorial is a call for action aiming at improving hypertension control in the transplant population.

    Continue Reading